Pharmacy preparations: Back in the limelight? Pharmacists make up your mind!

Crommelin, Daan J.A.; Bouwman-Boer, Yvonne

doi:10.1016/j.ijpharm.2016.09.031

Cited by 10 publications

(13 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A recent commentary article authored by academics in the Netherlands has called for a revival of education in pharmacy schools on topics that underpin pharmaceutics. Conceding that in some developed countries curricula has removed too much content that enables knowledge and skill competency in the areas of drug formulation and pharmaceutics [34]. The International Pharmaceutical Federation (FIP) supports a needs-based approach to guide pharmacy education [35].…”

Section: Discussionmentioning

confidence: 99%

Evaluation of Pharmaceutical Compounding Training in the Australian Undergraduate Pharmacy Curricula

et al. 2020

View full text Add to dashboard Cite

Introduction: In recent decades the role of the Australian community pharmacist has evolved to focus primarily on pharmaceutical care provision. Despite this, compounding remains an important product service offered by pharmacists. The aim of this study was to qualitatively describe the current integration of training in compounding within Bachelor of Pharmacy courses in Australia. Methods: The Australian Health Practitioner Regulatory Agency website was searched to identify eligible university courses. Subsequently, the educational providers’ homepages were consulted, and Bachelor of Pharmacy handbooks and curricula perused. All relevant information regarding training in compounding was extracted. Results: In total, 16 Bachelor of Pharmacy courses were identified. All of these contain compounding training in their curricula, including laboratory classes. Most curricula have units specifically dedicated to compounding and drug formulation. Three universities offer a curriculum which is organ-systems based, and include compounding relevant to the individual organ systems. Discussion and Conclusions: In Australia, the training in compounding is well integrated into pharmacy curriculum and is more emphasised than in many other developed countries. This is congruent with the International Pharmaceutical Federation’s needs-based approach to local pharmacy education. In Australia there is a need for pharmacists to routinely dispense simple compounded products. Further research is required to evaluate Australian pharmacy graduates’ compounding abilities and how best to promote the achievement of the required knowledge and skills to enable simple compounding.

show abstract

Section: Discussionmentioning

confidence: 99%

Evaluation of Pharmaceutical Compounding Training in the Australian Undergraduate Pharmacy Curricula

et al. 2020

View full text Add to dashboard Cite

show abstract

“…Although there is 1 definition of these pharmaceutical preparations in the EU, there is no uniformity in the interpretation of these preparations among all the countries because it is mostly regulated by national authorities . Here, we provide an overview of the different types of pharmaceutical preparations including their requirements and practical elaboration of these requirements for quality assurance and benefit‐risk assessments; see Figure , consisting of reconstitution in excess of SmPC preparation instructions, adaptation of a licensed medicinal product, and medicinal products from an API …”

Section: Unlicensed Pharmaceutical Preparationsmentioning

confidence: 99%

“…Reconstitution can be defined as “manipulation to enable the use or administration of a medicinal product for products with a marketing authorisation issued by any competent medicines regulatory authority, the reconstitution is carried out in accordance with the instructions given in the SmPC or the package leaflet,” according to the European Directorate of Quality of Medicines . Meaning, a preparation of a licensed medicinal product according to the SmPC via good nursing practice . In practice, reconstitution can be done in a more efficient way by preparing products on a larger scale in central units; eg, ready‐to‐administer syringes can be used as service products by various departments in the hospital.…”

Section: Unlicensed Pharmaceutical Preparationsmentioning

confidence: 99%

“…6,10 Here, we provide an overview of the different types of pharmaceutical preparations including their requirements and practical elaboration of these requirements for quality assurance and benefitrisk assessments; see Figure 1, consisting of reconstitution in excess of SmPC preparation instructions, adaptation of a licensed medicinal product, and medicinal products from an API. 17,18…”

Section: Pharmaceutical Preparation Typesmentioning

confidence: 99%

“…10 Meaning, a preparation of a licensed medicinal product according to the SmPC via good nursing practice. [17][18][19] In practice, reconstitution can be done in a more efficient way by preparing products on a larger scale in central units; eg, readyto-administer syringes can be used as service products by various Other formulation than a licensed product with that API No (licensed) formulation available with that API departments in the hospital. These pharmaceutical preparations are graded as high risk.…”

Section: Reconstitution In Excess Of Summary Of Product Characterismentioning

confidence: 99%

See 2 more Smart Citations

Unlicensed pharmaceutical preparations for clinical patient care: Ensuring safety

Wilde

Jong

Brun

et al. 2017

Pharmacoepidemiology and Drug

View full text Add to dashboard Cite

Most medicinal products dispensed to patients have marketing authorization (MA) to ensure high quality of the product, safety, and efficacy. However, in daily practice, to treat patients adequately, there is a medical need for drugs that do not hold MA. To meet this medical need, medicinal products are used in clinical care without MA (unlicensed), such as products prepared by (local) pharmacies: the pharmaceutical preparations. Three types of pharmaceutical preparations are distinguished: (i) reconstitution in excess of summary of product characteristics; (ii) adaptation of a licensed medicinal product (outside its official labeling); (iii) medicinal products from an active pharmaceutical ingredient. Although unlicensed, patients may expect the same quality for these unlicensed pharmaceutical preparations as for the licensed medicinal products. To assure this quality, a proper risk-benefit assessment and proper documentation in (centralized) patient registries and linking to a national pharmacovigilance database should be in place. Based on a risk assessment matrix, requirements for quality assurance can be determined, which has impact on the level of documentation of a pharmaceutical preparation.In this paper, the approach for good documentation including quality assurance and benefit-risk assessment will be discussed and possibilities for patient registries are described to make these crucial preparations available for regular patient care.

show abstract

Analytical aspects of printed oral dosage forms

Jacobsen

Rantanen

et al. 2018

International Journal of Pharmaceutics

View full text Add to dashboard Cite

Pharmacy preparations: Back in the limelight? Pharmacists make up your mind!

Cited by 10 publications

References 10 publications

Evaluation of Pharmaceutical Compounding Training in the Australian Undergraduate Pharmacy Curricula

Evaluation of Pharmaceutical Compounding Training in the Australian Undergraduate Pharmacy Curricula

Unlicensed pharmaceutical preparations for clinical patient care: Ensuring safety

Analytical aspects of printed oral dosage forms

Contact Info

Product

Resources

About